A carregar...
Publicação
Risco cardiovascular em doentes com infecção por vírus da imunodeficiência humana
| Nome: | Descrição: | Tamanho: | Formato: | |
|---|---|---|---|---|
| 236.94 KB | Adobe PDF |
Orientador(es)
Resumo(s)
The increased cardiovascular risk has been implicated in both HIV infection and antirretroviral therapy. The endothelial dysfunction triggered by the infection and the metabolic abnormalities associated with therapy predispose to premature atherosclerosis. The recognition of the increased cardiovascular risk in these patients will allow more appropriate prevention strategies, as well as therapy optimization with lipid-lowering agents and antirretroviral therapy modification.
Descrição
Palavras-chave
:IMMUNODEFICIENCY-VIRUS-INFECTION PROTEASE INHIBITOR THERAPY TREATMENT PANEL-III ANTIRETROVIRAL THERAPY METABOLIC SYNDROME INSULIN-RESISTANCE DYSLIPIDEMIA MANAGEMENT EFAVIRENZ ADULTS SDG 3 - Good Health and Well-being